CDXS Insider Trading Activity and SEC Form 4 Filings
CDXS insider trading summary
Over the past 12 months, insiders at Codexis, Inc. (CDXS) reported 37 sales worth $7.7M by 6 insiders and no open-market purchases on SEC Form 4. Net insider selling was $7.7M.
Latest CDXS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 12, 2026 | Alison Moore | President and CEO | Sell | $9K (6,335 @ $1.36) |
| Oct 12, 2026 | Georgia Erbez | See Remarks | Sell | $9K (6,335 @ $1.36) |
| Jun 11, 2026 | Vre Raymond De | Insider | Sell | $6K (2,605 @ $2.37) |
| Feb 24, 2026 | Stefan Lutz | Chief Scientific Officer | Sell | $7K (5,862 @ $1.13) |
| Feb 6, 2026 | Alison Moore | President and CEO | Sell | $5K (3,826 @ $1.31) |
| Feb 6, 2026 | Stefan Lutz | Chief Scientific Officer | Sell | $3K (2,492 @ $1.31) |
| Feb 6, 2026 | Georgia Erbez | See Remarks | Sell | $5K (3,826 @ $1.31) |
| Jan 7, 2026 | Stefan Lutz | CSO | Sell | $8K (4,685 @ $1.70) |
| Dec 1, 2025 | Opaleye Management Inc. | 10% Owner | Sell | $14K (8,533 @ $1.67) |
| Dec 1, 2025 | Opaleye Management Inc. | 10% Owner | Sell | $409K (245,000 @ $1.67) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.